Insilico Medicine named five humans, including CEO Alex Zhavoronkov, as inventors on a patent for a pulmonary fibrosis drug that its generative AI platform proposed, highlighting a US legal rule that …
Insilico Medicine is previewing a Virtual Aging Cell research direction that incorporates biological age into its virtual-cell models, aiming to improve predictions of cellular responses to genetic ed…
Bora Pharmaceuticals and Insilico Medicine announced a strategic alliance valued at more than $2.5 billion if fully implemented, combining Insilico's Pharma.AI platform for drug discovery with Bora's …
Insilico Medicine and SK Biopharmaceuticals announced a partnership valued at over $2.5 billion to use AI for developing neuroimmune therapies. Insilico will leverage its Pharma.AI platform for drug d…